Hangzhou-based healthcare company Nurotron Biotechnology Co., Ltd. says that it has raised as much as “a hundred million RMB” ($17 million) in series C funding from Kleiner Perkins Caufield Byers (KPCB) and DT Capital Partners, according to a company announcement. The specific amount and valuation of the investment were not disclosed. Nurotron previously received two […]
Visit ChinaMoneyNetwork.com for more great China Money Podcast audio and video Internet episodes covering important investment news and financial events in China, as well as daily news updates on important China business news happenings. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.